An evaluation of DUPAN-2 in pancreatic cancer and gastrointestinal disease.
作者信息
Cooper E H, Forbes M A, Taylor M
机构信息
Diagnostic Development Unit, University of Leeds, UK.
出版信息
Br J Cancer. 1990 Dec;62(6):1004-5. doi: 10.1038/bjc.1990.426.
Abstract
摘要
相似文献
1
An evaluation of DUPAN-2 in pancreatic cancer and gastrointestinal disease.DUPAN-2在胰腺癌和胃肠道疾病中的评估。
Br J Cancer. 1990 Dec;62(6):1004-5. doi: 10.1038/bjc.1990.426.
2
Clinical significance of serum carbohydrate antigen 19.9 and duke pancreatic monoclonal antigen type 2 for the prediction of hematogenous metastases in patients with pancreatic ducal adenocarcinoma.血清糖类抗原19.9和杜克胰腺单克隆抗原2对预测胰腺导管腺癌患者血行转移的临床意义
Pancreatology. 2016 Nov-Dec;16(6):1051-1056. doi: 10.1016/j.pan.2016.09.014. Epub 2016 Sep 26.
3
4
The detection of human pancreatic cancer-associated antigen in the serum of cancer patients.癌症患者血清中人类胰腺癌相关抗原的检测。
Cancer. 1987 Oct 1;60(7):1636-43. doi: 10.1002/1097-0142(19871001)60:7<1636::aid-cncr2820600736>3.0.co;2-c.
5
[Tumour markers of pancreatic cancer (tumour associated antigens)].[胰腺癌的肿瘤标志物（肿瘤相关抗原）]
Pol Arch Med Wewn. 2005 Jun;113(6):585-93.
6
Elevated serum levels of Dupan-2 in pancreatic cancer patients negative for Lewis blood group phenotype.Lewis血型表型阴性的胰腺癌患者血清中Dupan-2水平升高。
Br J Cancer. 1991 Nov;64(5):899-902. doi: 10.1038/bjc.1991.422.
7
Developments in serologic detection of human pancreatic adenocarcinoma.人类胰腺腺癌血清学检测的进展
Scand J Gastroenterol. 1999 Sep;34(9):833-44. doi: 10.1080/003655299750025273.
8
Clinical evaluation of a new serum tumour marker CA 242 in pancreatic carcinoma.一种新型血清肿瘤标志物CA 242在胰腺癌中的临床评估
Br J Cancer. 1992 May;65(5):731-4. doi: 10.1038/bjc.1992.154.
9
Peptide hormones as tumor markers in neuroendocrine gastrointestinal tumors.
Acta Oncol. 1991;30(4):477-83. doi: 10.3109/02841869109092404.
10
Predicting factors for unresectability in patients with pancreatic ductal adenocarcinoma.胰腺导管腺癌患者不可切除性的预测因素
J Hepatobiliary Pancreat Sci. 2014 Sep;21(9):648-53. doi: 10.1002/jhbp.109. Epub 2014 Apr 24.
引用本文的文献
1
Using Tumor Marker Gene Variants to Improve the Diagnostic Accuracy of DUPAN-2 and Carbohydrate Antigen 19-9 for Pancreatic Cancer.利用肿瘤标志物基因突变提高 DUPAN-2 和癌抗原 19-9 对胰腺癌的诊断准确性。
J Clin Oncol. 2024 Jun 20;42(18):2196-2206. doi: 10.1200/JCO.23.01573. Epub 2024 Mar 8.
2
Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket?在胰腺癌诊断中的生物标志物：我们是否更接近找到“金标准”？
World J Gastroenterol. 2021 Jul 14;27(26):4045-4087. doi: 10.3748/wjg.v27.i26.4045.
3
Functional Consequences of Differential O-glycosylation of MUC1, MUC4, and MUC16 (Downstream Effects on Signaling).MUC1、MUC4和MUC16的差异O-糖基化的功能后果（对信号传导的下游影响）
Biomolecules. 2016 Jul 30;6(3):34. doi: 10.3390/biom6030034.
4
Elevated serum levels of Dupan-2 in pancreatic cancer patients negative for Lewis blood group phenotype.Lewis血型表型阴性的胰腺癌患者血清中Dupan-2水平升高。
Br J Cancer. 1991 Nov;64(5):899-902. doi: 10.1038/bjc.1991.422.
本文引用的文献
1
Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies.由鼠单克隆抗体所界定的人胰腺腺癌细胞抗原
Cancer Res. 1982 Feb;42(2):601-8.
2
Detection of a pancreatic cancer-associated antigen (DU-PAN-2 antigen) in serum and ascites of patients with adenocarcinoma.腺癌患者血清和腹水中胰腺癌相关抗原（DU-PAN-2抗原）的检测
Proc Natl Acad Sci U S A. 1984 Aug;81(16):5242-6. doi: 10.1073/pnas.81.16.5242.
3
Comparison of a new tumour marker, CA 19-9, with alpha-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases.上消化道疾病患者中新型肿瘤标志物CA 19-9与甲胎蛋白和癌胚抗原的比较
J Clin Pathol. 1984 Feb;37(2):218-22. doi: 10.1136/jcp.37.2.218.
4
5
[Determination of serum DU-PAN-2 by enzyme immunoassay in patients with various digestive cancers].
Gan To Kagaku Ryoho. 1987 Jan;14(1):119-26.
6
7
Measurement of a pancreatic cancer-associated antigen (DU-PAN-2) detected by a monoclonal antibody in sera of patients with digestive cancers.用单克隆抗体检测消化系统癌症患者血清中一种胰腺癌相关抗原（DU-PAN-2）的测定。
Int J Cancer. 1986 May 15;37(5):693-6. doi: 10.1002/ijc.2910370509.
8
DU-PAN-2 levels in serum and pancreatic ductal fluids of patients with benign and malignant pancreatic disease.良性和恶性胰腺疾病患者血清和胰管液中的DU-PAN-2水平。
Pancreas. 1988;3(4):488-93. doi: 10.1097/00006676-198808000-00020.
9
Serum levels of cancer-associated antigen CA-195 in gastrointestinal cancers and its comparison with CA19-9.胃肠道癌症中癌相关抗原CA - 195的血清水平及其与CA19 - 9的比较。
J Clin Lab Anal. 1989;3(6):370-7. doi: 10.1002/jcla.1860030610.
Zotero 插件